Migraine sufferers urge health chiefs to overturn its decision to not offer erenumab on NHS England

A monthly injection of erenumab, the first new migraine drug for 20 years, was approved in Scotland in April. But in a blow to more than 500,000 people, NHS watchdog NICE rejected it in England.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news